2017 San Antonio Breast Cancer Symposium
Late Abstract Submission is now open. To submit a late abstract submission, please click here
We invite abstracts of proffered papers on the experimental
biology, etiology, prevention, diagnosis, and therapy of
breast cancer and premalignant breast disease.
Abstracts of superior quality will
be selected by the Symposium for presentation
at the 2017 San Antonio Breast Cancer
Symposium and published in February 2018 as a special online citable supplement to the AACR journal Cancer Research.
Abstracts, with the exception of those withheld for SABCS press conferences, will be released one month prior to the symposium. The abstracts withheld for press will be released at the beginning of the day on which the relevant press conference occurs. Slide presentations
and posters will be available for
viewing online during the Symposium at the SABCS website. Abstracts may be submitted electronically.
The scientific program consists of plenary lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from the submitted abstracts; educational sessions, award lectures, panel and case discussions and forums. General sessions are approximately 2 hours in duration and are the vehicle for slide presentations, which are allotted 10 minutes each followed by 5 minutes of discussion. Poster sessions are 1 1/2 to 2 hours long. Specific instructions for the preparation of slides and posters along with a draft copy of the program will be emailed to each presenter. They will also be available for viewing online at the SABCS website.
make sure you read "Abstract Presenter Responsibilities" before your
Abstract submission deadline was June 12, 2017
at 11:59 pm Central Time US.
Please notify the Symposium office as early as possible if your presentation will not be made, and reference your assigned program number. If a scheduled presenter fails to appear in person or to send a replacement, and does not cancel the poster or slide presentation before the meeting, that presenter will be barred from having an abstract accepted in the SABCS for three years. Notification must be sent in written form via email (email@example.com) or fax (210-450-1560).
This refers to abstracts submitted before the deadline for regular abstract submission but do not have results. This is only allowed for major clinical trials with implications on clinical practice or groundbreaking research findings. For placeholder abstracts, a final abstract containing complete results and the abstract file number is to be submitted by email to firstname.lastname@example.org
by September 15, 2017
. Placeholder abstracts that do not fulfill these criteria may be rejected. Placeholder claims must follow standard changes policy and deadlines. The deadline for placeholder abstract content and author revisions is September 15, 2017. The deadline for minor revisions is September 29, 2017. NOTE: You will be charged $25 for each revision. Send change requests to email@example.com you must include your abstract file number with your request. Only abstract body results will be updated for placeholder claims. Placeholder Abstracts are not part of the Late Abstract submission process and should not be submitted a second time.
Late Submission Abstracts
A late submission abstract refers only to paradigm shifting basic science discovery, or translational or clinical research of relevance to patients. Please note that, due to program schedule considerations, most if not all late submissions will be programmed as posters and scheduled on Saturday, December 9, 2017. This does not mean that there will not be any oral presentations selected from late submissions. Late submission abstract will open August 1, 2017. The deadline for all late submission abstract revisions is September 15, 2017.